메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Ispire Technology Inc. Schedules Fiscal Second Quarter 2026 Earnings Conference Call

LOS ANGELES, Feb. 3, 2026 -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its earnings conference call at 8:00 am ET on Friday, February 6, 2026, to discuss the Company's financial results for its fiscal second quarter ended December 31, 2025. To listen to the conference call, please dial in using the information below. When prompted upon dialing-in, please ask for the "Ispire Technology Call." Date: Friday, February 6, 2026
- 김갑성 기자
- 2026-02-03 20:00
Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082, a Next-Generation Anti-SIRPα Monoclonal Antibody for Advanced Solid Tumors

[ 메디채널 김갑성 기자 ] Milestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates (ADCs) and reinforces Biosion's "In Global, For Global" collaboration strategy. NEWARK, Del. and NANJING, China, Feb. 3, 2026 -- Biosion, Inc. ("Biosion"), a global, clinical-stage biotechnology company developing innovative antibody-based therapeutics, today announced that the first patient has been dosed in a Phase 1a/1b Investigator-Initiated Trial (IIT) evaluating BSI-082, a highly differentiated, fully human anti-SIRPα monocl
- 김갑성 기자
- 2026-02-03 17:31
Colebrook Bosson Saunders Officially Launches Lana, A Circular Ergonomic Laptop Stand for the Hybrid Generation

LONDON, Feb. 3, 2026 -- Colebrook Bosson Saunders (CBS), a leader in workplace ergonomics, today officially launches Lana, a next-generation laptop stand that combines ergonomic performance with circular design principles. Following a preview in January, Lana is now fully available across markets, offering organisations and individuals a practical solution designed for the realities of hybrid work. As workplaces continue to evolve toward flexible layouts and shared environments, CBS has rethought what ergonomic tools should deliver. Lana goes beyond addressing physical
- 김갑성 기자
- 2026-02-03 12:00
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager

SHANGHAI, Feb. 3, 2026 -- WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license and research service agreement with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) for an innovative trispecific T-cell Engager (TCE) for the treatment of B-cell mediated autoimmune diseases. Under the agreement, Vertex will have exclusive global rights to develop and commercialize an innovative trispecific TCE at the preclinical stage designed for the treatment of B-cell mediated autoimmune diseas
- 김갑성 기자
- 2026-02-03 11:22
Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai

TOKYO, Feb. 3, 2026 -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projects for the development of drugs, diagnostics and vaccines for malaria, tuberculosis (TB), and neglected tropical diseases (NTDs).2 Investment of JPY 648 million (approx. USD 4.1 million1) for development of an mRNA vaccine to reduce infection and transmission of vivax malariaMalaria caused by Plasmodium vivax remains a major challenge to malaria elimination efforts due to the parasite's ability to form d
- 김갑성 기자
- 2026-02-03 09:00
21 Asian Countries Among 93 Worldwide at Risk of Losing Nearly 23 Million More People by 2030

[ 메디채널 김갑성 기자 ] ISGlobal, supported by Rockefeller Foundation, analyzed impact of severe global aid cuts in 93 countries, with 21 in Asia New study published in The Lancet finds slashing global aid, particularly by US and European countries, will reverse decades of progress in fighting diseases BANGKOK, Feb. 3, 2026 -- The Lancet Global Health published a new peer-reviewed study today by the Barcelona Institute for Global Health (ISGlobal), which warns that a precipitous drop in global aid could lead to 22.6 million additional deaths by 2030 across 93 low- and middle- income coun
- 김갑성 기자
- 2026-02-03 07:40
ZEISS announces NMPA approval in China for powerful ophthalmic microscopes enhancing surgical visualization

ZEISS ARTEVO 750 and ZEISS ARTEVO 850 surgical microscopes provide ophthalmic surgeons in China with end-to-end workflow integration to improve efficiency, precision, and surgical safety. JENA, Germany and SHANGHAI, Feb. 3, 2026 -- ZEISS Medical Technology announced today that China's National Medical Products Administration (NMPA) has approved the ZEISS ARTEVO 750 and ARTEVO 850 ophthalmic microscopes. The microscopes provide high quality optical and digital visualization for both anterior and posterior segments. With upgrades spanning both hardware and software, the newly app
- 김갑성 기자
- 2026-02-03 07:00
ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging

SAN FRANCISCO, Feb. 2, 2026 -- On January 11, as the global healthcare industry gathered in San Francisco, the BIOSeedin Winter Innovation Partnering Summit successfully convened ahead of J.P. Morgan 2026. ACROBiosystems, as a key strategic partner, joined hands with multiple enterprises to participate in the event. Hosted by bioSeedin and centered on the theme "Global Matching of Innovative Assets," the summit brought together multinational pharmaceuticals, investors, and emerging biotech companies to explore licensing opportunities and globalization strategies for innovativ
- 김갑성 기자
- 2026-02-02 23:00
NYSE Content Advisory: Pre-Market update + AstraZeneca Shares Begin Trading on NYSE in Record Transfer

NEW YORK, Feb. 2, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market update + AstraZeneca Shares Begin Trading on NYSE in Record Transfer Kristen Scholer delivers the pre-market update on February 2nd The major indices are slightly lower to start the week as volatility in precious metals sparks risk‑off sentiment, though the S&P 500 remains about one percent from its recent
- 황정호 기자
- 2026-02-02 22:39
3Shape TRIOS 6 intraoral scanner wins the European Product Design Award (EPDA) 2025

COPENHAGEN, Denmark, Feb. 2, 2026 -- 3Shape today announced that the TRIOS 6 intraoral scanner has been honored with the European Product Design Award (EPDA) 2025 in the category Industrial/Healthcare: Medical Products. The EPDA Award Statement: "TRIOS 6 combines cutting-edge functionality with meticulous Danish design. Its sleek, pen-grip form reflects the precision of its advanced technology while ensuring effortless ergonomics. The new blue metallic finish introduces a fresh and modern aesthetic, and a level of design rarely seen in dental equipment. Complementing this is its a
- 김갑성 기자
- 2026-02-02 20:03

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 03일 01시 00분